Patents by Inventor Ni Ai
Ni Ai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11678734Abstract: Provided is a method for processing images. The method can include: acquiring a target face image, and performing face key point detection on the target face image to acquire a face key point detection result; determining a face visible area which is not subject to an occluder and a face invisible area which is subject to the occluder in the target face image; and acquiring a target fusion image by fusing a virtual special effect and a face part matched in the target face image based on the face key point detection result, the face visible area and the face invisible area.Type: GrantFiled: June 1, 2022Date of Patent: June 20, 2023Assignee: BEIJING DAJIA INTERNET INFORMATION TECHNOLOGY CO., LTD.Inventors: Shanshan Wu, Paliwan Pahaerding, Ni Ai
-
Publication number: 20220301341Abstract: Provided is a method for processing images. The method can include: acquiring a target face image, and performing face key point detection on the target face image to acquire a face key point detection result; determining a face visible area which is not subject to an occluder and a face invisible area which is subject to the occluder in the target face image; and acquiring a target fusion image by fusing a virtual special effect and a face part matched in the target face image based on the face key point detection result, the face visible area and the face invisible area.Type: ApplicationFiled: June 1, 2022Publication date: September 22, 2022Inventors: Shanshan WU, Paliwan PAHAERDING, Ni AI
-
Patent number: 11367307Abstract: Provided is a method for processing images. The method can include: acquiring a target face image, and performing face key point detection on the target face image; acquiring a first fusion image by fusing a virtual special effect and a face part matched in the target face image based on a face key point detection result; acquiring an occlusion mask of the target face image; and generating a second fusion image based on the occlusion mask and the first fusion image.Type: GrantFiled: November 25, 2020Date of Patent: June 21, 2022Assignee: Beijing Dajia Internet Information Technology Co., Ltd.Inventors: Shanshan Wu, Paliwan Pahaerding, Ni Ai
-
Publication number: 20210158021Abstract: Provided is a method for processing images. The method can include: acquiring a target face image, and performing face key point detection on the target face image; acquiring a first fusion image by fusing a virtual special effect and a face part matched in the target face image based on a face key point detection result; acquiring an occlusion mask of the target face image; and generating a second fusion image based on the occlusion mask and the first fusion image.Type: ApplicationFiled: November 25, 2020Publication date: May 27, 2021Inventors: Shanshan WU, Paliwan PAHAERDING, Ni AI
-
Patent number: 8455537Abstract: A method for preventing, diagnosing, or treating a condition mediated by an estrogen receptor by administering to a patient in need thereof an effective amount of a compound of formula I, II, or a combination thereof: wherein R1, R3, R4, and R5 are independently selected from H, OH, and ORa; R2 is selected from H, OH, and (C?O) (C1-7)alkyl; Ra is (C1-7)alkyl or (C?O)(C1-7)alkyl; or a derivative of the compound selected from N-oxide derivatives, prodrug derivatives, protected derivatives, isomers, and mixtures of isomers of the compound; or a pharmaceutically acceptable salt or solvate of the compound or the derivative. Compounds of formula I and II and pharmaceuticals compositions thereof are also presented.Type: GrantFiled: June 21, 2011Date of Patent: June 4, 2013Assignee: University of Medicine and Dentistry of New JerseyInventors: William J. Welsh, Ching Y. Wang, Ni Ai
-
Patent number: 8211882Abstract: The present invention discloses methods of modulating the activity of Group I mGluRs using a defined class of benzamide compounds. In one embodiment, methods of modulating the activity of mGluR1 are provided. In another embodiment, methods of modulating the activity of mGluR5 are provided. In still another embodiment, methods of simultaneously modulating the activities of both mGluR1 and mGluR5 are provided. The present invention also provides methods of treating diseases or disorders which are mediated in full or in part by Group I mGluRs using one or more compounds belonging to the defined class of benzamide compounds. The present invention further provides methods of preventing diseases or disorders which are mediated in full or in part by Group I mGluRs using one or more compounds belonging to the defined class of compounds.Type: GrantFiled: March 6, 2009Date of Patent: July 3, 2012Inventors: Richard Delarey Wood, William J Welsh, Sean Ekins, Ni Ai
-
Publication number: 20110319465Abstract: A method for preventing, diagnosing, or treating a condition mediated by an estrogen receptor by administering to a patient in need thereof an effective amount of a compound of formula I, II, or a combination thereof: wherein R1, R3, R4, and R5 are independently selected from H, OH, and ORa; R2 is selected from H, OH, and (C?O) (C1-7)alkyl; Ra is (C1-7)alkyl or (C?O)(C1-7)alkyl; or a derivative of the compound selected from N-oxide derivatives, prodrug derivatives, protected derivatives, isomers, and mixtures of isomers of the compound; or a pharmaceutically acceptable salt or solvate of the compound or the derivative. Compounds of formula I and II and pharmaceuticals compositions thereof are also presented.Type: ApplicationFiled: June 21, 2011Publication date: December 29, 2011Applicant: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEYInventors: William Welsh, Ching Y. Wang, Ni Ai
-
Patent number: 7989487Abstract: A method for preventing, diagnosing, or treating a condition mediated by an estrogen receptor by administering to a patient in need thereof an effective amount of a compound of formula I, II, or a combination thereof: wherein R1, R3, R4, and R5 are independently selected from H, OH, and ORa; R2 is selected from H, OH, and (C?O)(C1-7)alkyl; Ra is (C1-7)alkyl or (C?O)(C1-7)alkyl; or a derivative of the compound selected from N-oxide derivatives, prodrug derivatives, protected derivatives, isomers, and mixtures of isomers of the compound; or a pharmaceutically acceptable salt or solvate of the compound or the derivative. Compounds of formula I and II and pharmaceuticals compositions thereof are also presented.Type: GrantFiled: July 6, 2007Date of Patent: August 2, 2011Assignee: University of Medicine and Dentistry of New JerseyInventors: William J. Welsh, Nina Ching Y. Wang, Ni Ai
-
Publication number: 20100152271Abstract: A method for preventing, diagnosing, or treating a condition mediated by an estrogen receptor by administering to a patient in need thereof an effective amount of a compound of formula I, II, or a combination thereof: wherein R1, R3, R4, and R5 are independently selected from H, OH, and ORa; R2 is selected from H, OH, and (C?O)(C1-7)alkyl; Ra is (C1-7)alkyl or (C?O)(C1-7)alkyl; or a derivative of the compound selected from N-oxide derivatives, prodrug derivatives, protected derivatives, isomers, and mixtures of isomers of the compound; or a pharmaceutically acceptable salt or solvate of the compound or the derivative. Compounds of formula I and II and pharmaceuticals compositions thereof are also presented.Type: ApplicationFiled: July 6, 2007Publication date: June 17, 2010Applicant: UNIVERSIT OF MEDICINE AND DENISTRY OF NEW JERSEYInventors: William J. Welsh, Nina Ching Y. Wang, Ni Ai
-
Publication number: 20090239919Abstract: The present invention discloses methods of modulating the activity of Group I mGluRs using a defined class of benzamide compounds. In one embodiment, methods of modulating the activity of mGluR1 are provided. In another embodiment, methods of modulating the activity of mGluR5 are provided. In still another embodiment, methods of simultaneously modulating the activities of both mGluR1 and mGluR5 are provided. The present invention also provides methods of treating diseases or disorders which are mediated in full or in part by Group I mGluRs using one or more compounds belonging to the defined class of benzamide compounds. The present invention further provides methods of preventing diseases or disorders which are mediated in full or in part by Group I mGluRs using one or more compounds belonging to the defined class of compounds.Type: ApplicationFiled: March 6, 2009Publication date: September 24, 2009Inventors: Richard Delarey Wood, William J. Welsh, Sean Ekins, Ni Ai